NASHVILLE, Tenn., Feb. 11, 2016 -- AmSurg Corp. (Nasdaq:AMSG) today announced it will release its fourth quarter and year-end 2015 financial results on Wednesday, February 24, 2016, after the market closes. The Company will also host a conference call at 5:00 p.m. Eastern Time that same day. The live broadcast of AmSurg Corp.’s quarterly conference call will be available on-line by going to http://www.amsurg.com and clicking on the link to Investor Relations. The on-line replay will follow shortly after the call and continue for 30 days.
AmSurg’s Ambulatory Services Division acquires, develops and operates ambulatory surgery centers in partnership with physicians throughout the U.S. AmSurg’s Physician Services Division, Sheridan, provides outsourced physician services in multiple specialties to hospitals, ASCs and other healthcare facilities throughout the U.S., primarily in the areas of anesthesiology, children’s services, emergency medicine and radiology. Through these businesses as of September 30, 2015, AmSurg owned and operated 253 ASCs and one surgical hospital in 34 states and provided physician services to more than 360 healthcare facilities in 27 states. AmSurg has partnerships with, or employs, over 5,000 physicians in 38 states and the District of Columbia.
Contact: Claire M. Gulmi Executive Vice President and Chief Financial Officer (615) 665-1283


South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program 



